Global Gene Amplification Technologies Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Gene Amplification Technologies Market Overview

• 1.1 Product Overview and Scope of Gene Amplification Technologies
• 1.2 Classification of Gene Amplification Technologies by Types
  • 1.2.1 Global Gene Amplification Technologies Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Gene Amplification Technologies Revenue Market Share by Types in 2018
  • 1.2.3 Polymerase Chain Reaction (PCR)
  • 1.2.4 Loop Mediated Isothermal Amplification (LAMP)
  • 1.2.5 Other
• 1.3 Global Gene Amplification Technologies Market by Application
  • 1.3.1 Global Gene Amplification Technologies Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Medical
  • 1.3.3 Forensics
  • 1.3.4 Paternity
  • 1.3.5 Personnel Identification
  • 1.3.6 Food safety
  • 1.3.7 Other
• 1.4 Global Gene Amplification Technologies Market by Regions
  • 1.4.1 Global Gene Amplification Technologies Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Gene Amplification Technologies Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Gene Amplification Technologies Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Amplification Technologies Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Gene Amplification Technologies Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Amplification Technologies Status and Prospect (2014-2024)
• 1.5 Global Market Size of Gene Amplification Technologies (2014-2024)

2 Company Profiles

• 2.1 Abbott Laboratories
  • 2.1.1 Business Overview
  • 2.1.2 Gene Amplification Technologies Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Abbott Laboratories Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 BioMerieux
  • 2.2.1 Business Overview
  • 2.2.2 Gene Amplification Technologies Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 BioMerieux Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Bayer Corporation
  • 2.3.1 Business Overview
  • 2.3.2 Gene Amplification Technologies Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Bayer Corporation Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 QIAGEN
  • 2.4.1 Business Overview
  • 2.4.2 Gene Amplification Technologies Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 QIAGEN Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Roche Diagnostics
  • 2.5.1 Business Overview
  • 2.5.2 Gene Amplification Technologies Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Roche Diagnostics Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Agilent Technologies
  • 2.6.1 Business Overview
  • 2.6.2 Gene Amplification Technologies Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Agilent Technologies Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Cepheid
  • 2.7.1 Business Overview
  • 2.7.2 Gene Amplification Technologies Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Cepheid Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 BD
  • 2.8.1 Business Overview
  • 2.8.2 Gene Amplification Technologies Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 BD Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Rubicon Genomics
  • 2.9.1 Business Overview
  • 2.9.2 Gene Amplification Technologies Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Rubicon Genomics Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Bio-Rad Laboratories
  • 2.10.1 Business Overview
  • 2.10.2 Gene Amplification Technologies Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Bio-Rad Laboratories Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.11 Life Technologies
  • 2.11.1 Business Overview
  • 2.11.2 Gene Amplification Technologies Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Life Technologies Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)
• 2.12 Takara Bio
  • 2.12.1 Business Overview
  • 2.12.2 Gene Amplification Technologies Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Takara Bio Gene Amplification Technologies Revenue, Gross Margin and Market Share (2017-2018)

3 Global Gene Amplification Technologies Market Competition, by Players

• 3.1 Global Gene Amplification Technologies Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Gene Amplification Technologies Players Market Share
  • 3.2.2 Top 10 Gene Amplification Technologies Players Market Share
• 3.3 Market Competition Trend

4 Global Gene Amplification Technologies Market Size by Regions

• 4.1 Global Gene Amplification Technologies Revenue and Market Share by Regions
• 4.2 North America Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 4.3 Europe Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 4.5 South America Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Gene Amplification Technologies Revenue and Growth Rate (2014-2019)

5 North America Gene Amplification Technologies Revenue by Countries

• 5.1 North America Gene Amplification Technologies Revenue by Countries (2014-2019)
• 5.2 USA Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 5.3 Canada Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Gene Amplification Technologies Revenue and Growth Rate (2014-2019)

6 Europe Gene Amplification Technologies Revenue by Countries

• 6.1 Europe Gene Amplification Technologies Revenue by Countries (2014-2019)
• 6.2 Germany Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 6.3 UK Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 6.4 France Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 6.5 Russia Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 6.6 Italy Gene Amplification Technologies Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Gene Amplification Technologies Revenue by Countries

• 7.1 Asia-Pacific Gene Amplification Technologies Revenue by Countries (2014-2019)
• 7.2 China Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 7.3 Japan Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 7.4 Korea Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 7.5 India Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Gene Amplification Technologies Revenue and Growth Rate (2014-2019)

8 South America Gene Amplification Technologies Revenue by Countries

• 8.1 South America Gene Amplification Technologies Revenue by Countries (2014-2019)
• 8.2 Brazil Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Gene Amplification Technologies Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Gene Amplification Technologies by Countries

• 9.1 Middle East and Africa Gene Amplification Technologies Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 9.3 UAE Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Gene Amplification Technologies Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Gene Amplification Technologies Revenue and Growth Rate (2014-2019)

10 Global Gene Amplification Technologies Market Segment by Type

• 10.1 Global Gene Amplification Technologies Revenue and Market Share by Type (2014-2019)
• 10.2 Global Gene Amplification Technologies Market Forecast by Type (2019-2024)
• 10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2014-2024)
• 10.4 Loop Mediated Isothermal Amplification (LAMP) Revenue Growth Rate (2014-2024)
• 10.5 Other Revenue Growth Rate (2014-2024)

11 Global Gene Amplification Technologies Market Segment by Application

• 11.1 Global Gene Amplification Technologies Revenue Market Share by Application (2014-2019)
• 11.2 Gene Amplification Technologies Market Forecast by Application (2019-2024)
• 11.3 Medical Revenue Growth (2014-2019)
• 11.4 Forensics Revenue Growth (2014-2019)
• 11.5 Paternity Revenue Growth (2014-2019)
• 11.6 Personnel Identification Revenue Growth (2014-2019)
• 11.7 Food safety Revenue Growth (2014-2019)
• 11.8 Other Revenue Growth (2014-2019)

12 Global Gene Amplification Technologies Market Size Forecast (2019-2024)

• 12.1 Global Gene Amplification Technologies Market Size Forecast (2019-2024)
• 12.2 Global Gene Amplification Technologies Market Forecast by Regions (2019-2024)
• 12.3 North America Gene Amplification Technologies Revenue Market Forecast (2019-2024)
• 12.4 Europe Gene Amplification Technologies Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Gene Amplification Technologies Revenue Market Forecast (2019-2024)
• 12.6 South America Gene Amplification Technologies Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Gene Amplification Technologies Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology